Company / Current Liabilities
Cardiff Oncology, Inc. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$16.4M
FY2025
5-year range
$6.6M / $16.4M
FY2021-FY2025
Trend
+22.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has increased for 7 consecutive years, from $3M in FY2018 to $16M in FY2025.
Based on SEC 10-K filings.
$16M in FY2025 with a 5-year CAGR of +21.8%.
Increased from $10M to $16M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +28.1%
- 5-Year CAGR
- +21.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- Cardiff Oncology, Inc.'s current liabilities has grown for 7 consecutive years.
- 5-year CAGR of +21.8%, indicating consistent growth.
- In FY2025, current liabilities increased 22.1% year-over-year.
- Lowest current liabilities in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.4M | +22.1% |
| FY2024 | $13.4M | +28.6% |
| FY2023 | $10.4M | +33.7% |
| FY2022 | $7.8M | +19.0% |
| FY2021 | $6.6M | +7.2% |
| FY2020 | $6.1M | +28.0% |
| FY2019 | $4.8M | +61.3% |
| FY2018 | $3.0M | -24.8% |
| FY2017 | $3.9M | -49.4% |
| FY2016 | $7.8M | -4.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026